Concepedia

Author

S. Kim

Seoul National University HospitalORCID

Also Known As

S. Kim, Seokuee Kim

39

Publications

395

Citations

10

H-Index

22

Concepts

All Affiliations

Seoul National University HospitalKorea Innotech (South Korea)Samsung Medical CenterAsan Medical CenterSungkyunkwan University
SK

About

S. Kim is an author at Seoul National University Hospital specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

79

2

Pathology

2

2

52

3

Pharmacology

2

2

27

4

Health Sciences

1

1

14

5

Marrow Transplantation

1

1

14

S. Kim

×

10

Publications

292

Citations

10

H-Index

YearCitations

Night‐time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole

Eunsol Yang, S. Kim, Bongtae Kim,

British Journal of Clinical Pharmacology

2022

102

P1.15-004 An Open-Label, Multitumor Phase II Basket Study of Olaparib and Durvalumab (MEDIOLA): Results in Patients with Relapsed SCLC

Matthew Krebs, Kirsty Ross, S. Kim,

Journal of Thoracic Oncology

2017

32

Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects

Jong‐Lyul Ghim, May Chien Chin, Jin‐Ah Jung,

The Journal of Clinical Pharmacology

2020

31

Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study

Sungpil Han, Hee Youn Choi, Yo Han Kim,

Gut and Liver

2022

30

Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H:quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials

S. Kim, SeungHwan Lee, Joo‐Youn Cho,

Drug Design Development and Therapy

2017

22

Updated Safety and Efficacy from a Phase I Study of Azd9291 in Patients (Pts) with Egfr-Tki-Resistant Non-Small Cell Lung Cancer (Nsclc)

James Chih‐Hsin Yang, D. Kim, David Planchard,

Annals of Oncology

2014

20

Prediction of Drug–Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation

Deok Yong Yoon, SeungHwan Lee, In‐Jin Jang,

Pharmaceutics

2021

15

Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients

Hyewon Chung, Kyung Taek Hong, Ji Won Lee,

Bone Marrow Transplantation

2018

14

Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects

S. Kim, In‐Jin Jang, Dongseong Shin,

Journal of Clinical Pharmacy and Therapeutics

2014

13

No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects

Jung‐Ryul Kim, S. Kim, Wooseong Huh,

Drug Design Development and Therapy

2018

13

Page 1